Burrill
Tag details
Welcome to the 'Burrill' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Burrill'.
Look up
"Burrill"
at The Free Dictionary
Latest blogosphere posts tagged “Burrill”
-
Zoo shuts because of ice
Deadline Press & Picture Agency —
Authority: 488
Penguins enjoy Februarys snowfall at the zoo By Cara Sulieman ONE OF the country’s top tourist attractions closed its doors today (Sun) thanks to the wintry weather. Edinburgh Zoo – which is open every day of the year including Christmas – had to remain shut because ice had made the steep paths around the ...2 days ago -
Facet Board Pleased with Rejection of Biogen Bid
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: Facet Biotech ( FACT ) shareholders rejected Biogen Idecs ( BIIB ) bid to acquire the company for $493 million or $17.50 per share, while leaving the door open to a higher bid from Biogen or other potential suitors. For its part, after threatening to launch a proxy fight to unseat ...2 days ago -
Seattle Genetics Gets Boost from Cancer Drug Deal with Takeda
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: Seattle Genetics ( SGEN ) has scored a $365 million deal for commercialization of its late-stage Hodgkin’s lymphoma treatment SNG-35 with Millennium, Takedas ( TKPHF.PK ) U.S. cancer subsidiary. The deal provides a boost to the Seattle-based company, which days earlier saw Genentech ( ...2 days ago -
This Weeks Failed Trials, Missed Targets in Biotech
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: Gilead Sciences ( GILD ) said darusentan, the company’s experimental drug to treat resistant hypertension, failed in a late-stage clinical trial. Darusentan, an endothelin receptor antagonist, did not achieve its two primary endpoints in a comparison to a placebo. “We are ...2 days ago -
This Weeks Biotech Deal-Making and Financing
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: by MARIE DAGHLIAN In a busy week of deal-making and financing, Ambit Biosciences and Japan’s Astellas Pharma ( ALPMF.PK ) entered into a worldwide collaboration, potentially worth $390 million, to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology ...2 days ago -
Making Sense of a Tumultuous Year in Biotech
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: As 2009 began, a legislative battle around healthcare reform and a troubled economic environment stood ready to set the stage for the year. But a series of jaw-dropping acquisitions, robust partnering activity and a pick up in venture capital made the year a big one on the financing ...2 days ago -
Some of this year’s public interest heroes
Equal Justice Works Blog —
Authority: 109
In October, Equal Justice Works recognized three public interest law leaders for their commitments to service and low-income clients. The award winners – Scott Burrill , Larry Kramer and Bruce Sewell – represent the hundreds of law students, law school deans and corporate counsel that make our work ...5 days ago -
Crohn And Disease : Warts Pictures
Crohns Colitis IBD and IBS info —
Authority: 152
The man Burrill Bernard Crohn is known for his work in the field of gastroenterology, specifically for identifying the disease that has become his namesake; Crohns disease. He worked in New York at the Mount Sinai Hospital with two … Here is the original post: Crohn And Disease : Warts Pictures6 days ago -
Gift Guide: I like it. What is it?
Holiday Matinee —
Authority: 135
Oh Anthony Burrill, you kill us! Hot off the press and just in time for last minute holiday shoppers, Anthony dropped a new woodblock poster. It’s open edition, signed in pencil, 51×76 cm and printed on 100% recycled paper. And we love it! Buy it here .1 week ago -
Making and Breaking Biotech Deals
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: by MARIE DAGHLIAN Celgene ( CELG ) beefed up its blood cancer pipeline with the acquisition of privately-held Gloucester Pharmaceuticals for $340 million in cash plus $300 million in future U.S. and international regulatory milestone payments. Gloucester’s cancer treatment Istodax ...1 week ago -
Biotechs Latest Failed Trials, Missed Targets
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: Cytokinetics ( CYTK ) and GlaxoSmithKline ( GSK ) agreed to terminate their eight-year collaboration and license agreement on cancer drugs. The termination is effective February 28, 2010. As a result, all rights for GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), ...1 week ago -
I LIKE IT...
The Daily Duff —
Authority: 120
New Print from Anthony Burrill...3 weeks ago -
acid washed
alejandro cartagena —
Authority: 128
Acid Washed from Anthony Burrill on Vimeo .3 weeks ago -
Financing Drug Discovery: Recent Deals
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: by Marie Daghlian A smattering of deals and financings marked the relatively quiet days before Thanksgiving. San Diego-based biotech Receptos closed a two-tranche $25 million series A financing. The company is focused on identifying and developing best- and first-in-class therapeutic ...3 weeks ago -
anthony burrill: acid washed.
shape+colour —
Authority: 463
No words. Should’ve sent a poet. Some vintage-tinged graphic kick ass from U.K. designer Anthony Burrill .3 weeks ago -
Acid Washed
Doobybrain.com —
Authority: 575
Acid Washed from Anthony Burrill on Vimeo . Acid Washed by Anthony Burrill is a trippy short for music from the band Acid Washed .4 weeks ago -
Vitamin Beats Statin: Is Mercks Zetia in Trouble?
SeekingAlpha.com: Home Page —
Authority: 641
The Burrill Report submits: A small study is causing a big splash in the multi-billion dollar world of cholesterol treatments. The test, pitting a prescription form of the B vitamin niacin against the prescription drug ezetimibe, found that niacin significantly shrank artery walls when taken in combination with a ...4 weeks ago

